EMPLOYMENT AGREEMENTEmployment Agreement • April 1st, 2011 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
This Employment Agreement is made and entered into effective as of April 15, 2011, (the “Effective Date”), by and between Neoprobe Corporation, a Delaware Corporation with a place of business at 425 Metro Place North, Suite 300, Dublin, Ohio 43017-1367 (the “Company”) and Mark J. Pykett of Boxford, MA (the “Employee”).
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • April 1st, 2011 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
THIS SEPARATION AGREEMENT AND RELEASE (the “Agreement”) which becomes effective following the expiration of the revocation period set forth below in this Agreement, is entered into between Neoprobe Corporation, on behalf of itself and its partners, officers, employees and agents, the shareholders, directors, officers, employees and agents of its partners, and affiliated, predecessor, successor, and other related companies, and each of them, jointly and severally (herein singularly and collectively called “Neoprobe”), and David C. Bupp, on behalf of himself and his heirs, executors, guardians, administrators, successors, and assigns, and each of them, jointly and severally (herein singularly and collectively called “Executive”), who together are sometimes referred to herein as the “Parties” and who agree to be bound by all of the terms and conditions of this Agreement.
RELOCATION AGREEMENTRelocation Agreement • April 1st, 2011 • Neoprobe Corp • Surgical & medical instruments & apparatus
This Relocation Agreement (“Agreement”), is entered into by and between Neoprobe Corporation, an Ohio corporation (“Neoprobe”) and Mark J. Pykett, individually (“Employee”).
CONSULTING AGREEMENTConsulting Agreement • April 1st, 2011 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
This Consulting Agreement (“Agreement”) is made by and between David C. Bupp, an individual residing at 10542 Smokehouse Bay Drive, Naples, Florida 43120 (“Consultant”), and Neoprobe Corporation, a Delaware corporation, with principal offices located at 425 Metro Place North, Suite 300, Dublin, OH 43017-1367 (“Company”), who together are sometimes referred to herein as the “Parties.”
